ARGX Live signals | Maximize Profits with Getagraph.com

BUY 130 min ago

@ $449.41

Issued: 26 Jun 2024 @ 09:35

Return: -0.61%

Previous signal: Jun 24 - 09:31

Previous signal: Sell

Return: 2.83 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:45):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Stats
Today's Volume	150 235
Average Volume	272 396
Market Cap	26.54B
EPS	$-1.040 ( Q1 \| 2024-03-21 )
Next earnings date	( $-0.860 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-78.50 (Sector) 42.63 (Industry) 24.32
ATR14	$11.99 (2.69%)

AADI -3.53%

ABCL 2.01%

ABCM 0.04%

ABEO -2.13%

ABIO -2.23%

ABOS 0.00%

ABSI 1.87%

ABUS -2.30%

ABVX -2.03%

ACAD -0.48%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.50%

ACLX 0.09%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.68%

ADGI 0.87%

ADIL 0.54%

ADMA -2.82%

ADPT -0.15%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.30%

AKRO -2.70%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -1.38%

ALGS -1.81%

ALKS -0.14%

ALLK -9.32%

ALLO -5.00%

ALLR -3.37%

ALNA 3.16%

ALNY 2.28%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.38%

ALVR -0.40%

ALXN 0.00%

ALXO -11.12%

ALZN 2.04%

AMRN -0.72%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.75%

ANPC -3.15%

APGE -1.05%

APGN 8.48%

APGNW 30.65%

APLM -5.01%

APLS 0.27%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.72%

ARDS -14.23%

ARDX -0.58%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.30%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.85%

ARWR -1.56%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.11%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 1.70%

ATRA -2.83%

ATXI 1.93%

ATXS -0.67%

AUPH -0.90%

AURA 1.17%

AUTL -2.01%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.83%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.57%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.95%

BCAB 3.92%

BCDA -2.73%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.07%

BCTX 8.16%

BCTXW -17.41%

BCYC 1.20%

BDRX -4.94%

BDTX -0.85%

BEAM 0.87%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 4.49%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.24%

BMRN 0.50%

BNOX 4.61%

BNTC -0.42%

BNTX -1.86%

BOLD -8.58%

BOLT 0.72%

BPMC -1.09%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 24.37%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.04%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA -0.12%

CARM 10.43%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.44%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 7.24%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -0.88%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.19%

CGEN -3.87%

CGON -0.83%

CGTX -4.54%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.15%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.21%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.46%

CMPI 0.00%

CMPX -7.19%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -36.97%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.14%

COYA -1.46%

CPRX -1.12%

CRBP -3.34%

CRBU -4.83%

CRDF -0.89%

CRGX 0.47%

CRIS -0.38%

CRNX -6.00%

CRSP 1.22%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.85%

CTXR 2.01%

CUE 3.78%

CVAC -2.54%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 9.82%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.77%

CYTO -1.82%

DARE 6.41%

DAWN 0.37%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.55%

DNLI -1.54%

DNTH -8.84%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.96%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.62%

EDSA 3.19%

EFTR 4.64%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.45%

ELYM 2.30%

ENGN -4.44%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB -0.84%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.03%

EXAI -0.66%

EXEL -0.36%

EYEG -0.69%

EYEN 0.43%

EYPT 0.06%

FATE -8.06%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -4.18%

FENC -1.29%

FGEN -5.13%

FHTX 1.71%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.74%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.04%

FULC -3.85%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -2.16%

GLMD -2.33%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.50%

GLYC -9.31%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.91%

GNLX 1.10%

GNPX 0.98%

GNTA 3.94%

GOSS -10.46%

GOVX 4.55%

GOVXW -49.04%

GPCR -6.73%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.36%

GRTX 2.57%

GTHX 0.91%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.33%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.46%

HOOK -0.02%

HOTH -2.70%

HOWL -2.56%

HRMY 0.80%

HRTX 3.44%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 16.30%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.24%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.99%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.81%

INAB 0.00%

INBX 0.43%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.07%

INMB 2.66%

INO -1.95%

INSM -1.31%

INTS -2.75%

INVA 0.31%

INZY 1.03%

IOBT -11.11%

IONS 0.28%

IOVA -2.31%

IPA 2.50%

IPHA 5.58%

IPSC -1.95%

IRON -2.51%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 1.45%

JANX -4.18%

JAZZ -0.69%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.87%

KNTE -0.38%

KOD -6.92%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.16%

KTRA 16.19%

KTTA 8.16%

KTTAW 0.92%

KURA -1.51%

KYMR -2.60%

KYTX -4.14%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.11%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.95%

LPTX -1.65%

LQDA -0.73%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.35%

LYEL -33.58%

LYRA 0.93%

MACK 0.10%

MBIO -10.98%

MBRX -2.57%

MCRB 2.88%

MDGL -3.53%

MDNA -13.16%

MDWD 0.03%

MDXG -2.58%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX 0.54%

MIRM -1.89%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.57%

MLYS -6.41%

MNKD -0.95%

MNMD 0.42%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.20%

MORF -2.77%

MREO -4.29%

MRKR 2.68%

MRNA -5.05%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.22%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.72%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 9.24%

NKGNW 8.00%

NKTR -3.74%

NKTX -4.73%

NLSP 5.88%

NLSPW 26.67%

NMRA -3.66%

NMTR -42.97%

NOVN -24.84%

NRBO 12.63%

NRIX -0.34%

NRSN -5.18%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.60%

NTRBW -31.07%

NUVL -1.53%

NVAX -2.36%

NVCT 2.38%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.00%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA 0.00%

OCGN 3.83%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.00%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.49%

ORMP 21.48%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.29%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.48%

PDSB -3.50%

PEPG 2.56%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.40%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.19%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -10.64%

PRAX 0.59%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.60%

PRTA -2.74%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.18%

PSTX -0.78%

PTCT -0.71%

PTE -0.82%

PTGX -1.39%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.33%

RCKT -7.90%

REGN -0.26%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.29%

RLAY -3.56%

RLMD 0.33%

RLYB -0.34%

RNA 0.18%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.99%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.22%

RPTX -2.35%

RUBY 2.70%

RVLP -32.05%

RVMD -1.03%

RVMDW -30.00%

RVNC 2.34%

RVPH -2.36%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.74%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.83%

SANA -3.97%

SAVA -0.36%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.13%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -6.38%

SLGL 2.97%

SLN -4.76%

SLNO -4.03%

SLRX 6.07%

SLS -2.14%

SMMT -2.75%

SNDX 1.43%

SNGX -3.40%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.20%

SRRA 0.00%

SRRK -2.17%

SRZN -2.45%

STAB 0.00%

STOK -5.18%

STRO -2.68%

STSA 0.00%

STTK -2.39%

SURF -0.93%

SVRA -4.87%

SWTX 0.16%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 2.74%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.07%

TENX -1.27%

TERN -7.34%

TFFP -5.33%

TGTX -3.18%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -3.10%

TNGX -2.60%

TNXP -4.81%

TNYA -5.43%

TPST 2.67%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.14%

TSVT -2.93%

TTNP -7.79%

TVTX 0.88%

TYRA -7.43%

UBX -0.71%

UNCY -3.90%

URGN -1.52%

UTHR -0.38%

VACC 11.36%

VALN -2.89%

VAXX 83.69%

VBIV 0.78%

VBLT -8.77%

VCEL -0.16%

VCNX 10.35%

VCYT -1.03%

VERA -3.80%

VERU -0.57%

VERV -2.87%

VIGL 7.53%

VINC 2.96%

VIR 0.76%

VIRI -1.61%

VIRX 2.40%

VKTX -1.28%

VLON -13.04%

VNDA -2.61%

VOR -2.02%

VRCA 0.00%

VRDN -4.31%

VRNA -1.60%

VRPX 0.38%

VRTX 0.39%

VSTM -2.10%

VTGN -1.05%

VTVT -2.97%

VTYX -1.04%

VXRT -3.84%

VYGR -0.77%

VYNE -4.34%

VYNT 7.78%

WINT -3.24%

WVE -4.19%

XBIO 0.93%

XBIT -2.71%

XCUR 3.58%

XENE -2.81%

XERS 2.14%

XFOR 2.95%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.83%

ZNTL -0.83%

ZSAN 0.00%

Correlation (AI algo v.1.1b): Undervalued: 0.06% $446.92 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.82 (strong)

Short: -0.78 (moderate negative)

Signal:(39) Neutral

argenx SE Correlation

10 Most Positive Correlations
OZEM	1

10 Most Negative Correlations
RFAIU	-0.896
ERNZ	-0.895
INDH	-0.87

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

argenx SE Correlation - Currency/Commodity

-0.02
( neutral )

-0.43
( neutral )

-0.12
( neutral )

-0.05
( neutral )

-0.69
( moderate negative )

0.22
( neutral )

argenx SE Financials

Annual	2023
Revenue:	$1.23B
Gross Profit:	$1.11B (90.39 %)
EPS:	$-5.16

FY	2023
Revenue:	$1.23B
Gross Profit:	$1.11B (90.39 %)
EPS:	$-5.16

FY	2022
Revenue:	$410.75M
Gross Profit:	$381.32M (92.83 %)
EPS:	$-13.05

FY	2021
Revenue:	$497.28M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-7.99

Financial Reports:

No articles found.

argenx SE Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

argenx SE

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid and idiopathic inflammatory myopathy in Phase II/III clinical trials; and ENHANZE SC in Pre-clinical study. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; and ARGX-120 to treat autoimmune diseases. In addition, its partnered product candidates include ARGX-115 for the treatment of cancer; ARGX-112 to treat interleukin-22 receptor; and ARGX-114, an antibody directed against the MET receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands.